Botox vs Dysport vs Xeomin: What Actually Matters?
Share
One of the most common questions in aesthetics is whether Botox, Dysport, or Xeomin is "better." Patients often come in already leaning toward one because of social media, a friend's experience, or something they heard online. But the truth is, the answer is usually more nuanced than brand preference alone. All three are forms of botulinum toxin type A, which means they work by temporarily reducing targeted muscle activity. They are commonly used to soften repetitive expression lines in areas such as the forehead, frown lines, and crow's feet. In that sense, they are all designed to accomplish a very similar goal. What tends to matter more is not just which one is used, but how it is used, how the individual responds to it, and whether the treatment plan was appropriate in the first place.
At Aria Sonata Aesthetics, I currently offer Xeomin® and Dysport® rather than Botox®. Botox is included in this comparison because it remains the brand name many patients recognize first and is commonly used conversationally when referring to wrinkle-relaxing treatments.
One of the biggest misconceptions is that one product is dramatically stronger or more superior than the others across the board. In reality, all three can produce appropriate results when selected, dosed and planned carefully for the individual. The differences tend to show up in areas such as formulation, dosing considerations and individual patient response rather than in some universal ranking of best to worst.
Botox is often the most recognized name because it has been part of the public conversation the longest. Many patients ask for Botox simply because it has become almost synonymous with wrinkle treatment. Patients and providers sometimes describe differences in onset, treatment characteristics or how individual products behave in particular treatment patterns. However, these observations should not be treated as universal rules. Product behavior and clinical outcome depend on multiple factors, including dose, dilution, placement, anatomy and individual response.
Xeomin® (incobotulinumtoxinA) is manufactured using a purification process that removes complexing proteins from the botulinum neurotoxin preparation. Its formulation differs from Botox and Dysport, but formulation differences alone do not establish that one product is universally safer, better, longer lasting or more effective for every patient.
However, what most patients actually care about is not the formulation itself. They care about questions like: Will it look natural? Will I still look like myself? How long will it last? Will it make me look heavy or frozen? Those outcomes are influenced just as much by facial assessment, anatomical considerations, dosing strategy and candidacy as they are by the product selected.
Another important point is that the potency units assigned to botulinum toxin products are product-specific and should not be directly compared or converted as though they represent the same dose. Price-per-unit comparisons between different products can therefore be misleading without considering the dosing strategy used for that specific product and treatment area.
Patient response can also vary. Some patients feel they get a slightly smoother onset with one product, or a more predictable duration with another. Others feel no meaningful difference at all. Over time, many people settle into the one that seems to perform most consistently for their face, not because it is objectively superior, but because it works well for them individually.
The product selected is only one part of the outcome. Appropriate patient selection, facial assessment, dose, placement and treatment planning all contribute to the final result.
So what actually matters? The product matters, but it is only one part of treatment. Facial anatomy, movement patterns, treatment goals, appropriate dosing, placement and individual response all influence the result. Rather than choosing a neuromodulator based on popularity alone, treatment should be selected and planned for the individual.
At Aria Sonata Aesthetics, neurotoxin selection is not approached as a trend or a popularity contest. It is approached through anatomy, movement, patient goals, and long-term planning. Because what actually matters most is not what the internet says is best. It is what performs best for your face, your goals, and the way you want to age over time.
Not Sure Which Wrinkle Relaxer Is Right for You?
Treatment selection should begin with your anatomy, movement patterns and goals rather than brand recognition alone. Schedule a consultation to discuss which option may be appropriate for you.
Explore Xeomin treatment at Aria Sonata Aesthetics.